Even the robots are getting involved in science smile
It looks like the folks at CellAge are using robots to help them with their research and you can get one of these awesome “Marty” robots too when you support their project at Lifespan.io.
You can check out the campaign here at Lifespan.io:
https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/
Tissue engineering and Stem cells are a large part of the rejuvenation biotechnology toolkit. Here we have yet more progress and this time the pacemaker cells are replicated for possible use in biological pacemaker therapies.
“Scientists from the McEwen Centre for Regenerative Medicine, University Health Network, have developed the first functional pacemaker cells from human stem cells, paving the way for alternate, biological pacemaker therapy.”
A 14-year-old girl who said before dying of cancer that she wanted a chance to live longer has been allowed by the high court to have her body cryogenically frozen in the hope that she can be brought back to life at a later time.
The court ruled that the teenager’s mother, who supported the girl’s wish to be cryogenically preserved, should be the only person allowed to make decisions about the disposal of her body. Her estranged father had initially opposed her wishes.
During the last months of her life, the teenager, who had a rare form of cancer, used the internet to investigate cryonics. Known only as JS, she sent a letter to the court: “I have been asked to explain why I want this unusual thing done. I’m only 14 years old and I don’t want to die, but I know I am going to. I think being cryo‐preserved gives me a chance to be cured and woken up, even in hundreds of years’ time.
Hype aside demonstration that epigentic reprogramming can reverse some of the aging process is an important step forward for progress. We can expect to see this moving to human trials in the next decade or so making the future an exciting possibility.
Science is increasingly coming to the conclussion that aging is amenable to intervention and that it is a plastic process that we can manipulate. More research in this week shows that aging is indeed elastic and is not a one way process at all. The sooner society accepts what the data from the labs is showing the sooner we can cure age-related diseases for healthier longer lives!
“We did not correct the mutation that causes premature aging in these mice,” lead researcher Juan Carlos Izpisua Belmonte said in a recent statement. “We altered aging by changing the epigenome, suggesting that aging is a plastic process.”
More progress on the cancer front! Controlling cancer effectively is a critical part of rejuvenation biotechnology and therefore all cancer progress is of great interest to our community. If there was a poster child of aging diseases, cancer would be at the front of the queue.
“The results could lead to new treatments—not only for a variety of cancers, but also other diseases that arise from faulty proteinases, such as Alzheimer’s, asthma, multiple sclerosis and arthritis.”
Biologist Daisy Robinton talks about engineering aging and the possibilities new technology offers.
Harvard University biologist Daisy Robinton reveals how science is helping us understand how and why we age.
Daisy Robinton is a scientist at Harvard University researching mechanisms of stem cell identity at the intersection of cancer and developmental biology. Daisy’s passion for the effective translation of science has fuelled her years of teaching and speaking, and in 2011 Daisy founded the Science in the News Spring Public Lecture Series at Harvard. Daisy consults to numerous biotech startups in the US and UK and for projects ranging from feature film screenplays on the future of medicine and longevity to the “Future of Making” via bioengineering with IDEO.
Changes to gene activity that occur with age can be turned back, a new study shows.
A talk about how to make life extension mainstream.
Presentation by Didier Coeurnelle at Transpolitica 2016.
Treatments that enable radical healthy longevity should increasingly be seen as an ethical and economic necessity, and debated within the political mainstream.
Check out the LEAF interview with Synthetic Biology company CellAge who plan to use their technology to create aging biomarkers for the research community to use for free as well as new approaches to removing senescent cells.
CellAge are using synthetic biology to remove senescent cells that accumulate with age and contribute to disease. We took the time to interview them about their technology, treating age-related diseases and their plans for the future.
You can also check out their campaign on Lifespan.io:
https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/
